Year |
Citation |
Score |
2024 |
Castellano CA, Sun T, Ravindranathan D, Hwang C, Balanchivadze N, Singh SRK, Griffiths EA, Puzanov I, Ruiz-Garcia E, Vilar-Compte D, Cárdenas-Delgado AI, McKay RR, Nonato TK, Ajmera A, Yu PP, ... ... Beeghly A, et al. The impact of cancer metastases on COVID-19 outcomes: A COVID-19 and Cancer Consortium registry-based retrospective cohort study. Cancer. PMID 38376917 DOI: 10.1002/cncr.35247 |
0.376 |
|
2023 |
Harris HR, Peres LC, Johnson CE, Guertin KA, Beeghly A, Bandera EV, Bethea TN, Joslin CE, Wu AH, Moorman PG, Ochs-Balcom HM, Petrick JL, Setiawan VW, Rosenberg L, Schildkraut JM, et al. Racial Differences in the Association of Endometriosis and Uterine Leiomyomas With the Risk of Ovarian Cancer. Obstetrics and Gynecology. PMID 37159277 DOI: 10.1097/AOG.0000000000005191 |
0.368 |
|
2022 |
He J, Wen W, Beeghly A, Chen Z, Cao C, Shu XO, Zheng W, Long Q, Guo X. Integrating transcription factor occupancy with transcriptome-wide association analysis identifies susceptibility genes in human cancers. Nature Communications. 13: 7118. PMID 36402776 DOI: 10.1038/s41467-022-34888-0 |
0.339 |
|
2010 |
Lu L, Katsaros D, Qian B, Preti M, Menato G, Beeghly A, Yu H. Abstract 834: IGF-II promoter specific methylation patterns are associated with its expression and disease progression in epithelial ovarian cancer Cancer Research. 70: 834-834. DOI: 10.1158/1538-7445.Am10-834 |
0.597 |
|
2007 |
Beeghly AC, Katsaros D, Wiley AL, Rigault de la Longrais IA, Prescott AT, Chen H, Puopolo M, Rutherford TJ, Yu H. IGF-II promoter methylation and ovarian cancer prognosis. Journal of Cancer Research and Clinical Oncology. 133: 713-23. PMID 17569086 DOI: 10.1007/S00432-007-0211-3 |
0.534 |
|
2006 |
Wiley A, Katsaros D, Chen H, Rigault de la Longrais IA, Beeghly A, Puopolo M, Singal R, Zhang Y, Amoako A, Zelterman D, Yu H. Aberrant promoter methylation of multiple genes in malignant ovarian tumors and in ovarian tumors with low malignant potential. Cancer. 107: 299-308. PMID 16773633 DOI: 10.1002/Cncr.21992 |
0.568 |
|
2006 |
Beeghly A, Katsaros D, Chen H, Fracchioli S, Zhang Y, Massobrio M, Risch H, Jones B, Yu H. Glutathione S-transferase polymorphisms and ovarian cancer treatment and survival Gynecologic Oncology. 100: 330-337. PMID 16199080 DOI: 10.1016/J.Ygyno.2005.08.035 |
0.495 |
|
2004 |
Jones BA, Kasl SV, Howe CL, Lachman M, Dubrow R, Curnen MM, Soler-Vila H, Beeghly A, Duan F, Owens P. African-American/White differences in breast carcinoma: p53 alterations and other tumor characteristics. Cancer. 101: 1293-301. PMID 15368321 DOI: 10.1002/Cncr.20500 |
0.31 |
|
2002 |
Jones B, Kasl S, Soler H, Van Ness P, Howe C, Lachman M, Beeghly A, Dallal C, Duan F. #11 Race / ethnic differences in breast cancer survival Annals of Epidemiology. 12: 493-494. DOI: 10.1016/S1047-2797(02)00299-5 |
0.437 |
|
Show low-probability matches. |